Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist

Oncogene

Volumn 27, Issue 10, 2008, Pages 1421-1428

  Simmons, M J ^a,b,e   Fan, G ^a,b   Zong, W X ^a,b,f   Degenhardt, K ^a   White, E ^a,c,d   Gelinas C ^a,b,d  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f STONY BROOK UNIVERSITY   (United States)

Author keywords

A1; Apoptosis; Bak; Bcl2a1; Bfl 1; tBid

Indexed keywords

BCL2 RELATED PROTEIN A1; PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN MCL 1; PROTEIN TBID; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; WILD TYPE;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; HELA CELLS; HUMANS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 39849108605     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210771     Document Type: Article

References (41)